Biopharmaceutical Analytical Testing Services Market - 32% of Growth to Originate from North America |Increase in Demand for mAbs to Boost Market | 17000+ Technavio Reports

NEW YORK, Feb. 25, 2022 /PRNewswire/ -- The Biopharmaceutical Analytical Testing Services Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. 32% of the market's growth will originate from North America during the forecast period. The US is the key market for biopharmaceutical analytical testing services in North America. Market growth in this region will be slower than the growth of the market in APAC. The US and Canada will be the largest revenue contributing countries in the region as stable economies and strong infrastructure supports the launch of new drugs or biopharmaceuticals. The biopharmaceutical analytical testing services market size is expected to increase by USD 2.72 billion from 2020 to 2025, at a CAGR of 13.39%  as per the latest market report by Technavio.

For more insights on the biopharmaceutical analytical testing services market - Download a free sample now!

Market Dynamics

The key factor driving growth in the biopharmaceutical analytical testing services market is the increase in demand for mAbs. The global mAbs market is growing because mAbs are used for immunotherapy to stimulate immune responses to treat diseases. R and D for antibodies against diseases like Ebola, rheumatoid arthritis, and cancers are carried out. Cancer drug-conjugated mAbs cleave at the tumor site to provide targeted treatments. The increased demand for personalized medicine is a major factor in the enhanced demand for monoclonal antibodies. mAbs are produced in pharmaceutical and biotechnology companies to fulfill their increased demand. Therefore, mAbs are subjected to several quality control tests like microbial tests, sterility tests, and dissolution tests to ensure the quality of the mAbs. Thus, the rise in demand for mAbs will increase the demand for biopharmaceutical analytical testing services.

However, the shortage of trained professionals will be a major challenge for the biopharmaceutical analytical testing services market during the forecast period. Analytical testing requires skilled personnel and appropriate training. Pharmaceutical and biotechnology manufacturing facilities and laboratories want to produce products in short time spans. Therefore, the lack of required skills leads to a high degree of non-compliance among laboratory professionals. Improper testing and analysis of analytical tests may lead to product failures as they may not meet the regulatory requirements. The lack of recognition of the profession and lack of required knowledge about the importance of laboratory professionals are a few other factors that contribute shortage of trained personnel. This shortage of trained professionals is expected to continue during the forecast period thereby, offsetting the growth of the market.

To know about more drivers, trends & challenges - Download a free sample now!

Company Profiles

The biopharmaceutical analytical testing services market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market. The biopharmaceutical analytical testing services market report includes information on the product launches, sustainability, and prospects of leading vendors including Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Intertek Group Plc, Merck KGaA, SGS SA, Solvias AG, STERIS Plc, and West Pharmaceutical Services Inc.

Competitive Analysis

The competitive scenario provided in the biopharmaceutical analytical testing services market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.

Market Segmentation

• By End-user, the market is classified into pharma and biotech companies and CROs.
• By Geography, the market is classified as North America, Europe, APAC, South America, and MEA.

Related Reports 
Fertility Services Market -The fertility services market has the potential to grow by USD 5.27 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 6%. Download a free sample now!

Clinical Laboratory Services Market -The clinical laboratory services market size has the potential to grow by USD 159.14 billion during 2021-2025, and the market's growth momentum will decelerate at a CAGR of 10.42%. Download a  free sample now!

Table of Content

1. Executive Summary 

2. Market Landscape 

       2.1 Market ecosystem 

                 Exhibit 01: Parent market

       2.2: Market Characteristics 

3. Market Sizing 

       3.1 Market definition

                 Exhibit 02 Offerings of vendors included in the market definition

       3.2 Market segment analysis 

                 Exhibit 03: Market segments

       3.3 Market size 2020 

       3.4 Market outlook: Forecast for 2020 - 2025 

                 Exhibit 04: Global - Market size and forecast 2021-2026 ($ million)

                 Exhibit 05: Global - Market size and forecast 2021-2026 ($ million)

                 Exhibit 06: Global Market: Year-over-year growth 2021-2026 (%)

                 Exhibit 07: Global Market: Year-over-year growth 2021-2026 (%)

4. Five Forces Analysis 

       4.1 Five Forces Summary 

                 Exhibit 08: Five forces analysis 2020 & 2025

       4.2 Bargaining power of buyers 

       4.3 Bargaining power of suppliers 

       4.4 Threat of new entrants 

       4.5 Threat of substitutes 

       4.6 Threat of rivalry 

       4.7 Market condition

                 Exhibit 09: Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user 

       5.1 Market segments

                 Exhibit 10: End-user - Market share 2021-2026 (%)

                 Exhibit 11: End-user - Market share 2021-2026 (%)

       5.2 Comparison by End-user 

                 Exhibit 12: Comparison by End-user

                 Exhibit 13: Comparison by End-user

       5.3 Pharma and biotech companies - Market size and forecast 2021-2026 

                 Exhibit 14: Pharma and biotech companies - Market size and forecast 2021-2026 ($ million)

                 Exhibit 15: Pharma and biotech companies - Market size and forecast 2021-2026 ($ million)

                 Exhibit 16: Pharma and biotech companies - Year-over-year growth 2021-2026 (%)

                 Exhibit 17: Pharma and biotech companies - Year-over-year growth 2021-2026 (%)

       5.4 CROs - Market size and forecast 2021-2026 

                 Exhibit 18: CROs - Market size and forecast 2021-2026 ($ million)

                 Exhibit 19: CROs - Market size and forecast 2021-2026 ($ million)

                 Exhibit 20: CROs - Year-over-year growth 2021-2026 (%)

                 Exhibit 21: CROs - Year-over-year growth 2021-2026 (%)

       5.5 Market opportunity by End-user 

                 Exhibit 22: Market opportunity by End-user ($ million)

6 Customer Landscape 

       6.1 Customer landscape 

                 Exhibit 23: Customer landscape

7 Geographic Landscape 

       7.1 Geographic segmentation

                 Exhibit 24: Market share by geography 2021-2026 (%)

                 Exhibit 25: Market share by geography 2021-2026 (%)

       7.2 Geographic comparison 

                 Exhibit 26: Geographic comparison

                 Exhibit 27: Geographic comparison

       7.3 North America - Market size and forecast 2021-2026 

                 Exhibit 28: North America - Market size and forecast 2021-2026 ($ million)

                 Exhibit 29: North America - Market size and forecast 2021-2026 ($ million)

                 Exhibit 30: North America - Year-over-year growth 2021-2026 (%)

                 Exhibit 31: North America - Year-over-year growth 2021-2026 (%)

       7.4 Europe - Market size and forecast 2021-2026 

                 Exhibit 32: Europe - Market size and forecast 2021-2026 ($ million)

                 Exhibit 33: Europe - Market size and forecast 2021-2026 ($ million)

                 Exhibit 34: Europe - Year-over-year growth 2021-2026 (%)

                 Exhibit 35: Europe - Year-over-year growth 2021-2026 (%)

       7.5 APAC - Market size and forecast 2021-2026 

                 Exhibit 36: APAC - Market size and forecast 2021-2026 ($ million)

                 Exhibit 37: APAC - Market size and forecast 2021-2026 ($ million)

                 Exhibit 38: APAC - Year-over-year growth 2021-2026 (%)

                 Exhibit 39: APAC - Year-over-year growth 2021-2026 (%)

       7.6 South America - Market size and forecast 2021-2026 

                 Exhibit 40: South America - Market size and forecast 2021-2026 ($ million)

                 Exhibit 41: South America - Market size and forecast 2021-2026 ($ million)

                 Exhibit 42: South America - Year-over-year growth 2021-2026 (%)

                 Exhibit 43: South America - Year-over-year growth 2021-2026 (%)

       7.7 Middle East and Africa - Market size and forecast 2021-2026 

                 Exhibit 44: Middle East and Africa - Market size and forecast 2021-2026 ($ million)

                 Exhibit 45: Middle East and Africa - Market size and forecast 2021-2026 ($ million)

                 Exhibit 46: Middle East and Africa - Year-over-year growth 2021-2026 (%)

                 Exhibit 47: Middle East and Africa - Year-over-year growth 2021-2026 (%)

       7.8 US - Market size and forecast 2021-2026 

                 Exhibit 48: US - Market size and forecast 2021-2026 ($ million)

                 Exhibit 49: US - Market size and forecast 2021-2026 ($ million)

                 Exhibit 50: US - Year-over-year growth 2021-2026 (%)

                 Exhibit 51: US - Year-over-year growth 2021-2026 (%)

       7.9 China - Market size and forecast 2021-2026 

                 Exhibit 52: China - Market size and forecast 2021-2026 ($ million)

                 Exhibit 53: China - Market size and forecast 2021-2026 ($ million)

                 Exhibit 54: China - Year-over-year growth 2021-2026 (%)

                 Exhibit 55: China - Year-over-year growth 2021-2026 (%)

       7.10 Japan - Market size and forecast 2021-2026 

                 Exhibit 56: Japan - Market size and forecast 2021-2026 ($ million)

                 Exhibit 57: Japan - Market size and forecast 2021-2026 ($ million)

                 Exhibit 58: Japan - Year-over-year growth 2021-2026 (%)

                 Exhibit 59: Japan - Year-over-year growth 2021-2026 (%)

       7.11 UK - Market size and forecast 2021-2026

                 Exhibit 60: UK - Market size and forecast 2021-2026 ($ million)

                 Exhibit 61: UK - Market size and forecast 2021-2026 ($ million)

                 Exhibit 62: UK - Year-over-year growth 2021-2026 (%)

                 Exhibit 63: UK - Year-over-year growth 2021-2026 (%)

       7.12 Germany - Market size and forecast 2021-2026 

                 Exhibit 64: Germany - Market size and forecast 2021-2026 ($ million)

                 Exhibit 65: Germany - Market size and forecast 2021-2026 ($ million)

                 Exhibit 66: Germany - Year-over-year growth 2021-2026 (%)

                 Exhibit 67: Germany - Year-over-year growth 2021-2026 (%)

       7.13 Market opportunity by geography 

                 Exhibit 68: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends 

       8.1 Market drivers 

                 8.1.1 Increase in demand for mAbs

                 8.1.2 Increase in number of patent-expired drugs

                 8.1.3 Increase in chronic diseases

       8.2 Market challenges 

                 8.2.1 Shortage of trained professionals

                 8.2.2 Changing formulations in product design

                 8.2.3 Emergence of bioterrorism

       8.3 Impact of drivers and challenges 

                 Exhibit 69: Impact of drivers and challenges

       8.4 Market trends 

                 8.4.1 Rise in investment in R and D

                 8.4.2 Rise in production of vaccines

                 8.4.3 Increasing outsourcing of analytical testing services

9. Vendor Landscape 

       9.1  Competitive scenario 

       9.2  Vendor landscape 

                 Exhibit 70: Vendor Landscape

       9.3  Landscape disruption 

                 Exhibit 71: Landscape disruption

       9.4  Industry risks 

                 Exhibit 72: Industry risks

10.  Vendor Analysis 

       10.1  Vendors covered 

                 Exhibit 73: Vendors covered

       10.2 Market positioning of vendors 

                 Exhibit 74: Market positioning of vendors

       10.3 Boston Analytical 

                 Exhibit 75: Boston Analytical - Overview

                 Exhibit 76: Boston Analytical - Product / Service

                 Exhibit 77: Boston Analytical - Key news

                 Exhibit 78: Boston Analytical - Key offerings

       10.4 Catalent Inc. 

                 Exhibit 79: Catalent Inc. - Overview

                 Exhibit 80: Catalent Inc. - Business segments

                 Exhibit 81: Catalent Inc. - Key news

                 Exhibit 82: Catalent Inc. - Key offerings

                 Exhibit 83: Catalent Inc. - Segment focus

       10.5 Charles River Laboratories International Inc. 

                 Exhibit 84: Charles River Laboratories International Inc. - Overview

                 Exhibit 85: Charles River Laboratories International Inc. - Business segments

                 Exhibit 86: Charles River Laboratories International Inc. - Key news

                 Exhibit 87: Charles River Laboratories International Inc. - Key offerings

                 Exhibit 88: Charles River Laboratories International Inc. - Segment focus

       10.6 Curia Inc.

                 Exhibit 89: Curia Inc. - Overview

                 Exhibit 90: Curia Inc. - Product / Service

                 Exhibit 91: Curia Inc. - Key news

                 Exhibit 92: Curia Inc. - Key offerings

       10.7 Eurofins Scientific SE 

                 Exhibit 93: Eurofins Scientific SE - Overview

                 Exhibit 94: Eurofins Scientific SE - Business segments

                 Exhibit 95: Eurofins Scientific SE - Key news

                 Exhibit 96: Eurofins Scientific SE - Key offerings

                 Exhibit 97: Eurofins Scientific SE - Segment focus

       10.8 Intertek Group Plc 

                 Exhibit 98: Intertek Group Plc - Overview

                 Exhibit 100: Intertek Group Plc - Business segments

                 Exhibit 101: Intertek Group Plc - Key news

                 Exhibit 102: Intertek Group Plc - Key offerings

                 Exhibit 103: Intertek Group Plc - Segment focus

       10.9 Merck KGaA 

                 Exhibit 104: Merck KGaA - Overview

                 Exhibit 105: Merck KGaA - Business segments

                 Exhibit 106: Merck KGaA - Key news

                 Exhibit 107: Merck KGaA - Key offerings

                 Exhibit 108: Merck KGaA - Segment focus

       10.10 SGS SA

                 Exhibit 109: SGS SA - Overview

                 Exhibit 110: SGS SA - Business segments

                 Exhibit 111: SGS SA - Key news

                 Exhibit 112: SGS SA - Key offerings

                 Exhibit 113: SGS SA - Segment focus

       10.11 Solvias AG 

                 Exhibit 114: Solvias AG - Overview

                 Exhibit 115: Solvias AG - Product / Service

                 Exhibit 116: Solvias AG - Key news

                 Exhibit 117: Solvias AG - Key offerings

       10.12 West Pharmaceutical Services Inc. 

                 Exhibit 118: West Pharmaceutical Services Inc. - Overview

                 Exhibit 119: West Pharmaceutical Services Inc. - Business segments

                 Exhibit 120: West Pharmaceutical Services Inc. - Key news

                 Exhibit 121: West Pharmaceutical Services Inc. - Key offerings

                 Exhibit 122: West Pharmaceutical Services Inc. - Segment focus

11. Appendix  

       11.1 Scope of the report 

                 12.1.1 Market definition

                 12.1.2 Objectives

                 12.1.3 Notes and caveats

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio